Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy

Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy

Xinxu Zhang, Yuanyuan Deng, Juan Xiang, Huixia Liu, Jiani Zhang, Jie Liao, Ke Chen, Bo Liu, Jun Liu, Ying Pu Department of Geriatric Endocrinology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, People’s Republic of ChinaCorrespondence: Ying PuDepartment of Geriatric E...

Full description

Bibliographic Details
Main Authors:	Zhang X, Deng Y, Xiang J, Liu H, Zhang J, Liao J, Chen K, Liu B, Liu J, Pu Y
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-08-01
Series:	Drug Design, Development and Therapy
Subjects:	nonalcoholic fatty liver disease autophagy galangin 3-methyladenine free fatty acid.
Online Access:	https://www.dovepress.com/galangin-improved-non-alcoholic-fatty-liver-disease-in-mice-by-promoti-peer-reviewed-article-DDDT

Similar Items

Exploring the mechanism of galangin in alleviating alcoholic fatty liver disease based on the Gene Expression Omnibus database and network pharmacology
by: Yanan Zhao, et al.
Published: (2025-03-01)

Galangin mitigates glucocorticoid-induced osteoporosis by activating autophagy of BMSCs via triggering the PKA/CREB signaling pathway
by: Zeng Chenying, et al.
Published: (2023-06-01)

Mechanisms and therapeutic implications of selective autophagy in nonalcoholic fatty liver disease
by: Suwei Jin, et al.
Published: (2025-01-01)

Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
by: Yen-Ying Chen, et al.
Published: (2021-01-01)

Osteopontin acts as a negative regulator of autophagy accelerating lipid accumulation during the development of nonalcoholic fatty liver disease
by: Min Tang, et al.
Published: (2020-01-01)

Galangin alleviates alcoholic liver disease by regulating the gut-liver axis
by: Dongzhu Duan, et al.
Published: (2024-11-01)

Autophagy: a new target for nonalcoholic fatty liver disease therapy
by: Mao YQ, et al.
Published: (2016-03-01)

Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease
by: Zeng, Jialiu, et al.
Published: (2023)

Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways
by: Fei Zhou, et al.
Published: (2022-01-01)

Liraglutide Improves Nonalcoholic Fatty Liver Disease in Diabetic Mice by Activating Autophagy Through AMPK/mTOR Signaling Pathway
by: Liao Z, et al.
Published: (2024-02-01)

Inducible nitric oxide synthase accelerates nonalcoholic fatty liver disease progression by regulating macrophage autophagy
by: Guiyuan Jin, et al.
Published: (2023-12-01)

ADEMETHIONINE IN THERAPY OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: A. V. Polukhina, et al.
Published: (2017-11-01)

Omentin-1 mitigates non-alcoholic fatty liver disease by preserving autophagy through AMPKα/mTOR signaling pathway
by: Ziqing Huang, et al.
Published: (2024-12-01)

Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy [Corrigendum]
by: Zhang X, et al.
Published: (2021-01-01)

Treatment Options in Non-alcoholic Fatty Liver Disease
by: Won Kim
Published: (2017-06-01)

Hydrogen Sulfide Attenuates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Inhibiting Apoptosis and Promoting Autophagy via Reactive Oxygen Species/Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Signaling Pathway
by: Dongdong Wu, et al.
Published: (2020-11-01)

Antioxidant Properties of Galangin with β-cyclodextrin: An in Vitro and in Vivo
by: Zainab Abbas, et al.
Published: (2023-03-01)

Mitigation effect of galangin against aortic dysfunction and hypertrophy in rats with metabolic syndrome
by: Poungrat Pakdeechote, et al.
Published: (2023-05-01)

Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world
by: I. M. Iljinsky, et al.
Published: (2019-10-01)

Metformin Alleviates Hepatic Steatosis and Insulin Resistance in a Mouse Model of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Promoting Transcription Factor EB-Dependent Autophagy
by: Dan Zhang, et al.
Published: (2021-07-01)

Hepatic autophagy fluctuates during the development of non-alcoholic fatty liver disease
by: Hao Ding, et al.
Published: (2020-09-01)

Dietary compounds galangin and myricetin suppress ovarian cancer cell angiogenesis
by: Haizhi Huang, et al.
Published: (2015-05-01)

Analysis of Potential Amino Acid Biomarkers in Brain Tissue and the Effect of Galangin on Cerebral Ischemia
by: Ruocong Yang, et al.
Published: (2016-04-01)

Development and validation of HPTLC fingerprints of three species of Alpinia with biomarker Galangin
by: Anuradha S. Upadhye, et al.
Published: (2018-01-01)

Association of insulin resistance and non-alcoholic fatty liver disease
by: Ekaterina E. Mishina, et al.
Published: (2021-01-01)

Extracellular Vesicles as Drivers of Non-Alcoholic Fatty Liver Disease: Small Particles with Big Impact
by: David Højland Ipsen, et al.
Published: (2021-01-01)

Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
by: Margaret LP Teng, et al.
Published: (2023-04-01)

In Silico Target Identification of Galangin, as an Herbal Flavonoid against Cholangiocarcinoma
by: Brinda Balasubramanian, et al.
Published: (2022-07-01)

Transcriptional coordination of hepatic autophagy by nutrient-sensing nuclear receptor PPARα and FXR
by: Jae Man Lee
Published: (2016-12-01)

Therapeutic evaluation of galangin on cartilage protection and analgesic activity in a rat model of osteoarthritis
by: Yan Su, et al.
Published: (2021-09-01)

A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid
by: V.N. Santos, et al.
Published: (2003-06-01)

Non-alcoholic fatty liver disease and cognitive impairment
by: Elena V. Onuchina, et al.
Published: (2024-12-01)

Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study
by: Kil Woo Lee, et al.
Published: (2015-12-01)

Non-alcoholic fatty liver disease: treatment options based on pathogenic considerations
by: CM Oneta
Published: (2002-09-01)

Natural product nanozymes of herbal extract galangin in managing hepatocellular carcinoma
by: Erhao Wang, et al.
Published: (2024-06-01)

By Improving Regional Cortical Blood Flow, Attenuating Mitochondrial Dysfunction and Sequential Apoptosis Galangin Acts as a Potential Neuroprotective Agent after Acute Ischemic Stroke
by: Ming Cheng, et al.
Published: (2012-11-01)

Galangin’s potential as a functional food ingredient
by: Kit-Kay Mak, et al.
Published: (2018-07-01)

Development and validation of HPTLC method for simultaneous estimation of curcumin and galangin in polyherbal capsule dosage form
by: Sharad Kharat, et al.
Published: (2017-09-01)

Functional-morphological changes in non-alcoholic fatty liver disease after bariatric operations
by: Iu. I. Sedletskii, et al.
Published: (2019-02-01)

Serum Calcium and Phosphorus Concentration in Egyptian Patients with Non-Alcoholic Fatty liver disease
by: Mohammed F. Mohammed, et al.
Published: (2023-07-01)